Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Change in Account Payables (2016 - 2022)

American Healthcare REIT (AHR) has disclosed Change in Account Payables for 7 consecutive years, with -$184000.0 as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Change in Account Payables rose 96.43% year-over-year to -$184000.0, compared with a TTM value of -$184000.0 through Dec 2022, up 97.42%, and an annual FY2022 reading of -$184000.0, up 97.42% over the prior year.
  • Change in Account Payables was -$184000.0 for Q1 2022 at American Healthcare REIT, down from -$65000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $5.1 million in Q4 2020 and bottomed at -$5.2 million in Q1 2021.
  • Average Change in Account Payables over 5 years is -$100176.5, with a median of $18000.0 recorded in 2018.
  • The sharpest move saw Change in Account Payables skyrocketed 24552.38% in 2020, then tumbled 14842.86% in 2021.
  • Year by year, Change in Account Payables stood at $121000.0 in 2018, then tumbled by 117.36% to -$21000.0 in 2019, then surged by 24552.38% to $5.1 million in 2020, then tumbled by 101.27% to -$65000.0 in 2021, then crashed by 183.08% to -$184000.0 in 2022.
  • Business Quant data shows Change in Account Payables for AHR at -$184000.0 in Q1 2022, -$65000.0 in Q4 2021, and -$1.9 million in Q3 2021.